Atrial Fibrillation
Q&A: AI transforming electrophysiology, but ‘preserving the humanism’ necessary
Few areas in medicine have been impacted by AI as much as cardiac electrophysiology. While still in early stages, it is already influencing how electrophysiologists detect disease and predict outcomes.
Top in cardiology: Implant for coronary artery disease; Fasting vs. no fasting
Results from the INFINITY-SWEDEHEART trial showed that Elixir Medical’s drug-eluting coronary implant was noninferior to a drug-eluting stent for target lesion failure at 1 year.
Catching up on sleep over the weekend may have heart health benefits
Catching up on sleep over the weekend was associated with lower likelihood of having heart disease compared with individuals who slept less than they would during the week, a speaker reported.
Stopping abelacimab may not be necessary before invasive procedures
Patients with atrial fibrillation needing stroke prevention assigned to abelacimab had very low rates of bleeding during invasive procedures, according to new data from the AZALEA-TIMI 71 trial.
For patients with AF, HFrEF, cryoballoon noninferior to radiofrequency ablation
In patients with atrial fibrillation and heart failure with reduced ejection fraction, cryoballoon ablation was noninferior to radiofrequency ablation, according to the results of the CRABL-HF trial.
Mass ECG screening for atrial fibrillation in older adults does not seem to prevent stroke
Mass ECG screening for atrial fibrillation in older adults did not reduce the incidence of stroke or stroke hospitalization, according to the results of two trials presented at the European Society of Cardiology Congress.
Prevalence of atrial fibrillation in US adults much higher than previous estimates
Nearly one in 20 adults in the U.S. are estimated to have atrial fibrillation, many more than previous studies had indicated, according to new data out of the University of California, San Francisco.
Quitting smoking appears to reduce risk for atrial fibrillation
Among people who had ever smoked, those who quit had reduced risk for incident atrial fibrillation compared with those who had not, according to new data from the UK Biobank.
Top in cardiology: Composite biomarker predicts risk; processed food and heart disease
A single combined measurement of three modifiable biomarkers can predict future cardiovascular events when measured in healthy women at midlife, according to research presented at the European Society of Cardiology Congress.
Real-world data confirm benefits of ravulizumab for atypical hemolytic uremic syndrome
Adults and children with atypical hemolytic uremic syndrome who switched from eculizumab to ravulizumab had stable renal function and hematologic values with similar safety seen in clinical trials, according to data from a registry study.